摘要
目的探讨生长抑素受体(somatostatin receptor,SSTR)1~3亚型蛋白在胃癌发生、发展中的作用及其相关性。方法对病理确诊的47例胃癌组织标本采用免疫组化二步法检测SSTR1~3亚型蛋白的表达。采用Fisher精确概率法分析临床相关因素与上述指标的相关性。结果SSTR1—3亚型蛋白的表达与患者的性别、肿瘤的部位、有无淋巴结转移及临床分期无统计学意义(P〉0.05);20例浸润型胃癌SSTR1阳性表达率为50.O%,26例溃疡型胃癌中SSTR1阳性表达率为80.77%,两组比较有显著性差异(P〈0.05);14例高/中分化SSTR2阳性率为71.43%,33例低分化SSTR2阳性率为30.30%,两组比较有显著性差异(P〈0.05);20例浸润型胃癌SSTR3阳性表达率为30.00%,26例溃疡型胃癌中SSTR3阳性表达率为69.23%,两组比较有显著性差异(P〈0.05);14例高/中分化SSTR3阳性率为78.57%,33例低分化SSTR3阳性率为42.42%,两组比较有显著性差异(P〈0.05)。结论SSTR1~3亚型可能与胃癌的发生、发展有关,并参与抑制胃癌细胞的增殖。
Objective To study the role of somatostatin receptor (SSTR) subtypes 1 - 3 in the process of genesis, development of gastric carcinoma and their relationship. Methods Two-step immunohistochemical staining was used to examine the expressions of SSTR1 -3 in 47 cases of gastric specimens, then the relationship between them and clinical pathology was analyzed by Fisher test. Results The expressions of SSTR1 - 3 were not related to gender, the location, lymph node metastasis and clinical stage (P 〉0.05) ; the expression rates of SSTR1 and SSTR3 in 20 cases of invaded gastric carcinoma (50. 00% , 30.00% ) were lower than that in 26 cases of ucler gastric carcinoma (80.77% , 69.23% )(P 〈 0.05); the expression rates of SSTR2 and SSTR3 in 14 cases of high/middle differentiation degree (71.43%, 78.57% ) were higher than that in 33 cases of low differentiation degree (31.25%, 42.42% ) ( P 〈 0.05 ). Conclusion SSTR1 - 3 may play an important role in the development and genesis of gastric carcinoma, and it inhibites the proliferation of gastric carcinoma.
出处
《胃肠病学和肝病学杂志》
CAS
2008年第10期826-828,共3页
Chinese Journal of Gastroenterology and Hepatology
关键词
胃癌
生长抑素
生长抑素受体
免疫组化
Gastric carcinoma
Somatostatin
Somatostatin receptor
Immunohistochemistry